Telik, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs in the United States. Its primary product candidate, TELCYTA, is a small molecule tumor-activated cancer product candidate, which is being evaluated for the treatment of cancers that are resistant to standard chemotherapy drugs. The TELCYTA is in three Phase 3 registration trials for the treatment of advanced ovarian cancer, nonsmall cell lung cancer, and refractory ovarian cancer. The company's another product candidate, TELINTRA, is a small molecule bone marrow stimulant, which is being developed for the treatment of blood disorders associated with low blood cell levels, such as neutropenia or anemia. The TELINTRA is in Phase 2 trial in patients with myelodysplastic syndrome. Telik has collaboration agreements with Sanwa Kagaku Kenkyusho Co., Ltd. and Hoffmann-La Roche, Inc. The company was formed as Terrapin Diagnostics, Inc. in 1988 and changed its name to Terrapin Technologies, Inc. in 1989. Further, Terrapin Technologies changed its name to Telik, Inc. in 1998. Telik is based in Palo Alto, California.
Premarket, intraday, nightly, and weekend updates, which include stock picks with full instructions, market direction (short, intermediate, long term), precious metal, commodity, and currency analysis.
Provide you stock picks (breakouts) and market direction to help you become
more profitable.
Voice over chart updates sent to you by e-mail. These updates contain stock picks and market status for a number of different portfolios, which Trending123 is recommending and following.
Instantaneous e-mail alerts during the trading day when targets have been hit or the status of a position or the market warrants a move. Stock Recommendations for swing traders, day traders, and long term investors.
Receive instant emails to your computer, organizer, cell phone of breakouts on stocks.....Learn More
Stock quotes, stock research, stock scan and picks and free stock chart pattern recognition from Trending 123.com for smart stock market investing. We feature daily stock market email alerts including equities, indices, and currencies, identified through technical analysis trends patterns and waves. Sign up today!
Financial Market Data powered by Quotemedia.com. All rights reserved. Terms and conditions.
NYSE/AMEX data delayed 20 minutes. NASDAQ/other data delayed 15 minutes unless indicated.
